Boston venture capital firm Third Rock Ventures announced the launch of a genomic search engine company in strategic partnership with Sanofi SA, the French drug maker that recently bought Genzyme Corp. of Cambridge for $20.1 billion. The new company --- Warp Drive Bio --- will have $125 million in initial financing. Alexis Borisy, partner at Third Rock Ventures, is the interim chief executive officer of Warp Drive Bio.